4th Mar 2008 17:53
United Drug PLC04 March 2008 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (1) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (2) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (3) An issuer making a notification in respect of options grantedto a director/person discharging managerial responsibilities should completeboxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) 3 Name of DIRECTOR 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify Mr. Barry McGrane the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Election of scrip dividend alternative offer relating to dividend for year end 30 September 2007 Mr. Barry McGrane 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired 0.00002% 5,010 Ordinary Shares of €0.05 each 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 27 February 2008 5,010 @ €3.72 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 445,402 Ordinary Shares of €0.05 each (0.002%) If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 23 Any additional information 24 Name of contact and telephone number for queries N/a Karen Geoghegan (01-4637720) Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 04/03/2008 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (5) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (6) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (7) An issuer making a notification in respect of options grantedto a director/person discharging managerial responsibilities should completeboxes 1 to 3 and 17 to 24. (8) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) 3 Name of DIRECTOR 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify Mr. Chris Corbin the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Election of scrip dividend alternative offer relating to dividend for year end 30 September 2007 Mr. Chris Corbin (1,822,410) Ms. Sam Corbin (5,950) 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired 0.0001% 24,431 Ordinary Shares of €0.05 each 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 27 February 2008 24,431 @ €3.72 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 1,852,791 Ordinary Shares of €0.05 each (0.008%) If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 23 Any additional information 24 Name of contact and telephone number for queries N/a Karen Geoghegan (01-4637720) Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 04/03/2008 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (9) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (10) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (11) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (12) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) 3 Name of DIRECTOR 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify Mr. Kieran McGowan the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Election of scrip dividend alternative offer relating to dividend for year end 30 September 2007 Davycrest Nominees 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/a 551 Ordinary Shares of €0.05 each 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 27 February 2008 551 @ €3.72 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 48,558 Ordinary Shares of €0.05 each (0.0002%) If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 23 Any additional information 24 Name of contact and telephone number for queries N/a Karen Geoghegan (01-4637720) Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 04/03/2008 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (13) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (14) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (15) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (16) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) 3 Name of DIRECTOR 4 State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify Mr. Philip Toomey the connected person N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Election of scrip dividend alternative offer relating to dividend for year end 30 September 2007 Mr. Philip Toomey 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/a 879 Ordinary Shares of €0.05 each 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 27 February 2008 879 @ €3.72 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 77,569 Ordinary Shares of €0.05 each (0.0003%) If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 23 Any additional information 24 Name of contact and telephone number for queries N/a Karen Geoghegan (01-4637720) Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 04/03/2008 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (17) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (18) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (19) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (20) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) 3 Name of PERSON DISCHARGING MANAGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person Mr. Michael Dunne N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Election of scrip dividend alternative offer relating to dividend for year end 30 September 2007 Mr. Michael Dunne 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/a 340 Ordinary Shares of €0.05 each 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 27 February 2008 340 @ €3.72 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 30,423 Ordinary Shares of €0.05 each (0.0001%) If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 23 Any additional information 24 Name of contact and telephone number for queries N/a Karen Geoghegan (01-4637720) Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 04/03/2008 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (21) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (22) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (23) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (24) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) 3 Name of PERSON DISCHARGING MANAGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person Mr. Luke Brehony N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Election of scrip dividend alternative offer relating to dividend for year end 30 September 2007 Mr. Luke Brehony 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/a 41 Ordinary Shares of €0.05 each 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 27 February 2008 41 @ €3.72 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 17,070 Ordinary Shares of €0.05 each (0.00007%) If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 23 Any additional information 24 Name of contact and telephone number for queries N/a Karen Geoghegan (01-4637720) Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 04/03/2008 SCHEDULE 11 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons This form is intended for use by an issuer to make a RIS notification requiredby the Market Abuse Rules and section 53 (as extended by section 64 of theCompanies Act 1990) or entered into the issuer's register in accordance withsection 59 of the Companies Act 1990. (25) An issuer making a notification in respect of a transactionrelating to the shares or debentures of the issuer should complete boxes 1 to16, 23 and 24. (26) An issuer making a notification in respect of a derivativerelating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,16, 23 and 24. (27) An issuer making a notification in respect of options granted toa director/person discharging managerial responsibilities should complete boxes1 to 3 and 17 to 24. (28) An issuer making a notification in respect of a financialinstrument relating to the shares of the issuer (other than a debenture) shouldcomplete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. All relevant boxes should be completed in block capital letters 1 Name of the Issuer 2 State whether the notification relates to: United Drug plc (i) a transaction notified in accordance with Market Abuse Rules; (ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii) 3 Name of PERSON DISCHARGING MANAGERIAL 4 State whether notification relates to a person connected with a person RESPONSIBILITY discharging managerial responsibilities/director named in 3 and identify the connected person Mr. Vincent Long N/A 5 Indicate whether the notification is 6 Description of shares (including class) debentures or derivatives or in respect of a holding of the person financial instruments relating to shares referred to in 3 or 4 above or in respect of a non-beneficial interest Ordinary Shares of €0.05 each. As per 3 above 7 Name of registered shareholder(s) 8 State the nature of the transaction and, if more than one, number of shares held by each of them Election of scrip dividend alternative offer relating to dividend for year end 30 September 2007 Mr. Vincent Long 9 Number of shares, debentures or 10 Percentage of issued class acquired (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares acquired N/a 100 Ordinary Shares of €0.05 each 11 Number of shares, debentures or 12 Percentage of issued class disposed (treasury shares of that class financial instruments relating to should not be taken into account when calculating percentage) shares disposed N/a N/a 13 Price per share or value of 14 Date and place of transaction transaction 27 February 2008 100 @ €3.72 15 Total holding following notification 16 Date issuer informed of transaction and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 10,541 Ordinary Shares of €0.05 each (0.00005%) If a person discharging managerial responsibilities has been granted options bythe issuer, complete the following boxes: 17 Date of grant 18 Period during which or date on which it can be exercised 19 Total amount paid (if any) for grant 20 Description of shares or debentures involved of the option (class and number) 21 Exercise price (if fixed at time of 22 Total number of shares or debentures over grant) or indication that the price which options are held following is to be fixed at the time of notification exercise 23 Any additional information 24 Name of contact and telephone number for queries N/a Karen Geoghegan (01-4637720) Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 04/03/2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
UDG.L